<DOC>
	<DOCNO>NCT02407340</DOCNO>
	<brief_summary>This study examine utility neuropeptide oxytocin ( OT ) potential new medication treatment Alcohol use disorder ( AUD ) . Non-treatment seek men woman AUD enrol double blind placebo control phase I clinical trial . Participants complete 7-day inpatient protocol . During first 3 day inpatient protocol , participant complete alcohol abstinence withdrawal symptom measure , urine collect determine withdrawal symptom severity urine level stress hormone cortisol . Participants complete 3 laboratory procedure measure 1 ) stress response , 2 ) motivation drink alcohol 3 ) subjective physiological effect alcohol . Finally , participant individual AUD , administer brief intervention address risky alcohol drinking problem discharge .</brief_summary>
	<brief_title>Laboratory Studies Oxytocin Treatment Alcohol Use Disorder</brief_title>
	<detailed_description>This study lay necessary groundwork future comprehensive research examine utility neuropeptide oxytocin ( OT ) potential new medication treatment Alcohol use disorder ( AUD ) . OT modulate number key system involve addiction process , include dopamine ( DA ) mesolimbic reward circuitry , hypothalamic-pituitary-adrenal ( HPA ) axis corticotrophin-releasing factor ( CRF ) stress system , low abuse liability . Our overarch hypothesis OT attenuate several measure think drive compulsive alcohol drinking relapse . Specifically , examine whether OT decrease acute stress response , alleviate alcohol withdrawal symptom , reduces crave motivation drink , decrease alcohol self-administration . Since interaction alcohol important focus study , enroll non-treatment seek heavy drinker AUD double blind , placebo control inpatient protocol . Subjects randomize receive intranasal OT ( 40 IU/dose ) placebo 3 time daily . Participants complete alcohol detoxification ; measure alcohol withdrawal symptom , crave , 24-hr urinary free CORT . Participants complete 3 laboratory procedure fix order . The Trier Social Stress Test ( TSST ) include public speak performance mental arithmetic use examine subjective physiological stress response . An alcohol motivate responding ( AMR ) procedure use examine subject ' respond earn either drink money . A cumulative alcohol-dosing ( CAD ) procedure use examine physiological subjective response across several blood alcohol level . CORT level also assess . This study provide new information OT efficacy across range different measure predictive alcohol use misuse , , OT show efficacy , help clarify mechanism OT action .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Alcohol-Related Disorders</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Healthy 2150 year old male female subject Must meet DSMV criterion AUD seek treatment Actively drink Positive blood PEth ( &gt; 8 ng/mL ) Current DSMV major current mood anxiety disorder drug use disorder ( exclude alcohol nicotine ) ; need treatment Drug use last 30 day and/or positive urine toxicology screen ( exclude marijuana ) History seizure disorder close head trauma History withdrawalrelated seizure serious alcohol withdrawal symptom HIV positive Neuroendocrine disorder Any serious medical condition would place subject risk interfere study participation Liver function test &gt; 3X time normal screen Prescription medication last 3 month could affect CNS HPA axis function Women pregnant , nurse plan pregnancy participate</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Alcohol Withdrawal Delirium</keyword>
</DOC>